In TCGA uterine corpus endometrial carcinoma samples, there were nine (SOX17, C3, PAX8, ESR1, MME, MSR1, BNC2, IRF6, and PGR) genes with >5% alteration frequency. This evidence concerns the gene C3 and uterine corpus endometrial carcinoma.